Agios Pharmaceuticals to Present at 30th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the field of cancer metabolism, today announced that David Schenkein, M.D., chief executive officer, is scheduled to present at the 30th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2012 at 11:30 AM PST at the Westin St. Francis Hotel in San Francisco.